Light Mode
$160.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $160.00, and at the day’s high of $160.00
+14.36 (+9.86%) / 6M
Momentum, market sentiment, and recent alerts
NVSEF reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +33.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.